NL
DE
Our mission
We aim to improve treatment outcomes and quality of life for patients with chronic inflammatory diseases (CID) by fostering interdisciplinary, cross-disease collaboration and translational research that integrates clinical and experimental approaches to deliver personalized and effective care.
Goals
- To apply the most recent therapy modalities and optimize medication use, including dose reduction strategies, to enhance patient treatment.
- To develop and implement personalized monitoring systems, including home-based options, to provide tailored patient care.
- To improve early diagnosis and disease classification by combining current diagnostic criteria with precise clinimetrics, imaging techniques, and biomarker measurements.
- To investigate the impact of sex differences, age, pregnancy, and family planning on treatment response to refine personalized care.
- To support curiosity-driven preclinical research to unravel disease mechanisms, develop human and disease models, and identify novel drug targets through drug screening and repurposing strategies.
- To promote collaboration between laboratories and clinical departments to bridge experimental and clinical disciplines for better patient outcomes.
- To contribute to preventing complex disease progression and reducing healthcare costs through optimized, interdisciplinary care.
